Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tobramycin, dexamethasone, and diclofenac regimens for prevention of pseudophakic macular edema
2016-004416-35Phase 4Completed
- Sponsor
- Fundació Parc Taulí
- Start
- Apr 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tobramycin, dexamethasone and diclofenac in Irvine-Gass syndrome (IGS) and cystoid macular edema (CME) (3 arms), sponsored by Fundació Parc Taulí. Primary endpoint: Increase in macular thickness on OCT. Started Apr 2017; status: completed.
02
Drugs
tobramycindexamethasonediclofenac
03
Conditions
Irvine-Gass syndrome (IGS)cystoid macular edema (CME)
Beyond the preview
Go deeper on 2016-004416-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004416-35.